$10.67
00.00%
Pre-Market: 7:34 AM EDT
15 minutes delayed
Comments
Loading...
ORIC Pharmaceuticals (ORIC) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestORIC Pharmaceuticals (NASDAQ:ORIC) Stock Quotes, Forecast and News Summary
ORIC Pharmaceuticals Stock (NASDAQ: ORIC) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 165.00 / 566.00K |
| Day Range | - - - |
| 52 Wk Range | 5.27 - 16.65 |
| Market Cap | $752.69M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 61 |
| Short Interest | 18.23% |
| Days to Cover | 36.74 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About ORIC Pharmaceuticals Inc
Sector
Health Care
Industry
Biotechnology
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapi...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy ORIC Pharmaceuticals (ORIC) stock?
You can purchase shares of ORIC Pharmaceuticals (NASDAQ:ORIC) through any online brokerage.
Who are ORIC Pharmaceuticals (ORIC) competitors?
Other companies in ORIC Pharmaceuticals’s space includes: 89bio (NASDAQ:ETNB), Humacyte (NASDAQ:HUMA), 4D Molecular Therapeutics (NASDAQ:FDMT), Replimune Group (NASDAQ:REPL) and Tango Therapeutics (NASDAQ:TNGX).
What is the forecast, or price target, for ORIC Pharmaceuticals (ORIC) stock?
ORIC Pharmaceuticals has a consensus price target of $19.44.
What is the current price for ORIC Pharmaceuticals (ORIC)?
The stock price for ORIC Pharmaceuticals (NASDAQ: ORIC) is $10.67 last updated September 19, 2024 at 7:34 AM EDT.
Does ORIC Pharmaceuticals (ORIC) pay a dividend?
There are no upcoming dividends for ORIC Pharmaceuticals.
When is ORIC Pharmaceuticals (NASDAQ:ORIC) reporting earnings?
ORIC Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 4, 2024.
Is ORIC Pharmaceuticals (ORIC) going to split?
There is no upcoming split for ORIC Pharmaceuticals.
What sector and industry does ORIC Pharmaceuticals (ORIC) operate in?
ORIC Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.